The International Cholangiocarcinoma Research Network (ICRN) is a global collaboration of more than 175 clinicians and researchers from renowned institutions who are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment, and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share a passion to make significant scientific advances to improve outcomes for patients with cholangiocarcinoma.
Mitesh Borad, MD Assistant Professor of Medicine and Director of Phase I Drug Development at Mayo Clinic in Arizona, ICRN Chair; and Nilofer Azad, MD Associate Professor of Oncology at Johns Hopkins, ICRN Vice Chair, invite all professionals who's clinical and research interests are focused on cholangiocarcinoma to join the ICRN.
Individual/Institution ICRN membership is free and open to properly credentialed scientists and researchers whose clinical/research interests are focused on cholangiocarcinoma.
- Convene regularly with a global network of renown cholangiocarcinoma clinicians and researchers and join relevant Interest Groups
- Collaborate with other members from worldwide institutions on multi-center clinical trials and other projects
- Develop a cohesive industry strategy through working with the CCF Industry Council
- Opportunities for faculty and leadership roles
- Access to funding streams facilitated by CCF
- Access to the CCF International Cholangiocarcinoma Patient Registry (ICPR)
- Sign a Confidentiality Disclosure Agreement (CDA) with CCF/ICRN
- Actively participate in ICRN meetings and initiatives
- Acknowledge CCF in publications stemming from ICRN work
To join the ICRN, please submit the online membership application.
For more information, please contact Donna.Mayer@cholangiocarcinoma.org.